Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GemmaCert is a life sciences technology company that provides professional-grade, non-destructive solutions for the analysis of cannabis and hemp. Utilizing Near-Infrared (NIR) spectroscopy combined with advanced image processing and machine learning, the company's patented technology allows for the real-time measurement of cannabinoid potency and water activity without the need for sample preparation or lab expertise. Their flagship desktop device is used by growers, dispensaries, and labs worldwide to ensure quality control and consistency in medicinal cannabis products. The company aims to set a global standard for cannabis testing, making it accessible and affordable across the supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GemmaCert.